Inflectra the first biosimilar monoclonal antibody to be approved in Europe
Hospira has announced the European Commission ( EC ) approval of Inflectra ( Infliximab ), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of ...
read article